Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Genetron says early liver cancer screening research results cited in guidelines » 07:30
02/09/21
02/09
07:30
02/09/21
07:30
GTH

Genetron

$28.23 /

+0.74 (+2.69%)

Genetron announced that…

Genetron announced that its early liver cancer screening research results were cited by the "Chinese Anti-Cancer Association Guidelines for Patients with Primary Liver Cancer". The guidelines, issued by the Chinese Anti-Cancer Association, are the first national-level patient-oriented full-process guidelines for liver cancer prevention and treatment in China. In the section on early liver cancer screening, the guidelines emphasized that "Liquid biopsies based on circulating tumor DNA (ctDNA) have shown significant value in early screening for liver cancer. The combined detection of mutation and methylation, in combination with traditional protein biomarkers can achieve better screening results." The liquid biopsy-based early liver cancer screening study, jointly published by Genetron Health and the National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences in the Proceedings of the National Academy of Sciences, or PNAS, was cited in the guidelines indicating awareness and regard for Genetron's research among the expert community.

ShowHide Related Items >><<
GTH Genetron
$28.23 /

+0.74 (+2.69%)

GTH Genetron
$28.23 /

+0.74 (+2.69%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
  • 19
    Jun
GTH Genetron
$28.23 /

+0.74 (+2.69%)

Over a month ago
Conference/Events
Genetron management to meet virtually with BTIG » 05:55
01/20/21
01/20
05:55
01/20/21
05:55
GTH

Genetron

$23.34 /

+3.13 (+15.49%)

Virtual Meetings to be…

Virtual Meetings to be held January 19-20 hosted by BTIG.

ShowHide Related Items >><<
GTH Genetron
$23.34 /

+3.13 (+15.49%)

GTH Genetron
$23.34 /

+3.13 (+15.49%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$23.34 /

+3.13 (+15.49%)

  • 19
    Jun
GTH Genetron
$23.34 /

+3.13 (+15.49%)

Conference/Events
Genetron management to meet virtually with BTIG » 04:55
01/19/21
01/19
04:55
01/19/21
04:55
GTH

Genetron

$20.15 /

-1.12 (-5.27%)

Virtual Meetings to be…

Virtual Meetings to be held January 19-20 hosted by BTIG.

ShowHide Related Items >><<
GTH Genetron
$20.15 /

-1.12 (-5.27%)

GTH Genetron
$20.15 /

-1.12 (-5.27%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$20.15 /

-1.12 (-5.27%)

  • 19
    Jun
GTH Genetron
$20.15 /

-1.12 (-5.27%)

Conference/Events
Genetron management to meet virtually with BTIG » 10:57
01/15/21
01/15
10:57
01/15/21
10:57
GTH

Genetron

$20.38 /

-0.89 (-4.18%)

Virtual Meetings to be…

Virtual Meetings to be held January 19-20 hosted by BTIG.

ShowHide Related Items >><<
GTH Genetron
$20.38 /

-0.89 (-4.18%)

GTH Genetron
$20.38 /

-0.89 (-4.18%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$20.38 /

-0.89 (-4.18%)

  • 19
    Jun
GTH Genetron
$20.38 /

-0.89 (-4.18%)

On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:32
01/06/21
01/06
16:32
01/06/21
16:32
MRNA

Moderna

$116.27 /

+7.25 (+6.65%)

, CHA

China Telecom

$28.85 /

+0.33 (+1.16%)

, CHU

China Unicom

$6.13 /

-0.02 (-0.33%)

, CHL

China Mobile

$27.70 /

-1.65 (-5.62%)

, BABA

Alibaba

$227.58 /

-12.84 (-5.34%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

, ABC

AmerisourceBergen

$106.15 /

+8.43 (+8.63%)

, WBA

Walgreens Boots Alliance

$43.05 /

+1.89 (+4.59%)

, UNH

UnitedHealth

$359.37 /

+14.85 (+4.31%)

, CHNG

Change Healthcare

$23.72 /

+5.475 (+30.01%)

, TSLA

Tesla

$756.20 /

+20.72 (+2.82%)

, DKNG

DraftKings

$49.00 /

+1.45 (+3.05%)

, GTH

Genetron

$15.66 /

+2.01 (+14.73%)

, DNMR

Danimer Scientific

$24.85 /

+2.2 (+9.71%)

, IMRA

Imara

$14.69 /

-9.05 (-38.12%)

, NEO

NeoGenomics

$51.35 /

-3.47 (-6.33%)

Stock futures were mostly…

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$43.05 /

+1.89 (+4.59%)

UNH UnitedHealth
$359.37 /

+14.85 (+4.31%)

TSLA Tesla
$756.20 /

+20.72 (+2.82%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

NEO NeoGenomics
$51.35 /

-3.47 (-6.33%)

MRNA Moderna
$116.27 /

+7.25 (+6.65%)

IMRA Imara
$14.69 /

-9.05 (-38.12%)

GTH Genetron
$15.66 /

+2.01 (+14.73%)

DNMR Danimer Scientific
$24.85 /

+2.2 (+9.71%)

DKNG DraftKings
$49.00 /

+1.45 (+3.05%)

CHU China Unicom
$6.13 /

-0.02 (-0.33%)

CHNG Change Healthcare
$23.72 /

+5.475 (+30.01%)

CHL China Mobile
$27.70 /

-1.65 (-5.62%)

CHA China Telecom
$28.85 /

+0.33 (+1.16%)

BABA Alibaba
$227.58 /

-12.84 (-5.34%)

ABC AmerisourceBergen
$106.15 /

+8.43 (+8.63%)

MRNA Moderna
$116.27 /

+7.25 (+6.65%)

01/06/21 Piper Sandler
Moderna price target raised to $170 after EU vaccine approval at Piper Sandler
01/04/21 Piper Sandler
Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
CHA China Telecom
$28.85 /

+0.33 (+1.16%)

03/24/20 CLSA
China Telecom upgraded to Outperform from Underperform at CLSA
03/24/20 Macquarie
China Telecom upgraded to Outperform from Neutral earlier at Macquarie
CHU China Unicom
$6.13 /

-0.02 (-0.33%)

09/30/20 Nomura
China Unicom upgraded to Buy from Neutral at Nomura
03/23/20 Macquarie
China Unicom upgraded to Outperform from Neutral at Macquarie
03/23/20 Credit Suisse
China Unicom upgraded to Outperform from Neutral at Credit Suisse
03/23/20 Credit Suisse
China Unicom upgraded to Outperform from Neutral at Credit Suisse
CHL China Mobile
$27.70 /

-1.65 (-5.62%)

07/13/20 New Street
China Mobile downgraded to Reduce from Neutral at New Street
03/19/20 New Street
China Mobile upgraded to Buy from Reduce at New Street
BABA Alibaba
$227.58 /

-12.84 (-5.34%)

12/29/20 Truist
Truist lowers Alibaba SOTP valuation but believes that break-up is unlikely
12/28/20 UBS
Pinduoduo, JD could benefit if Alibaba forced to be less aggressive, says UBS
12/24/20 Raymond James
Raymond James remains buyer of Alibaba, thinks antitrust worries priced in
12/24/20 Loop Capital
iQIYI price target lowered to $18 from $25 at Loop Capital
TCEHY Tencent
$0.00 /

+ (+0.00%)

01/05/21 New Street
Tencent named a top idea for 2021 at New Street
01/05/21 Jefferies
Yeahka initiated with a Buy at Jefferies
12/15/20 Credit Suisse
Prosus initiated with an Outperform at Credit Suisse
ABC AmerisourceBergen
$106.15 /

+8.43 (+8.63%)

01/07/21 Deutsche Bank
AmerisourceBergen price target raised to $115 from $111 at Deutsche Bank
01/06/21 BofA
AmerisourceBergen upgraded to Neutral from Underperform at BofA
11/18/20 Jefferies
Drug distributors' pullback on Amazon news an overreaction, says Jefferies
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
WBA Walgreens Boots Alliance
$43.05 /

+1.89 (+4.59%)

01/05/21 Truist
Walgreens Boots Alliance price target raised to $44 from $40 at Truist
12/04/20 Credit Suisse
Walgreens leverage buyout math 'could still work,' says Credit Suisse
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
UNH UnitedHealth
$359.37 /

+14.85 (+4.31%)

01/07/21 Cowen
Change Healthcare downgraded to Market Perform from Outperform at Cowen
01/07/21 Deutsche Bank
UnitedHealth price target raised to $404 from $359 at Deutsche Bank
01/07/21 RBC Capital
Change Healthcare downgraded to Sector Perform from Outperform at RBC Capital
01/07/21 Citi
Change Healthcare downgraded to Neutral from Buy at Citi
CHNG Change Healthcare
$23.72 /

+5.475 (+30.01%)

01/07/21 Truist
Change Healthcare downgraded to Hold from Buy at Truist
TSLA Tesla
$756.20 /

+20.72 (+2.82%)

01/07/21
RBC Capital upgraded Tesla to Sector Perform, re-evaluates its position in EV
01/07/21 RBC Capital
Tesla upgraded to Sector Perform from Underperform at RBC Capital
01/07/21 Deutsche Bank
BMW downgraded to Hold from Buy at Deutsche Bank
01/06/21 Credit Suisse
Credit Suisse upgrades Li Auto to Outperform on sales momentum, autonomous plans
DKNG DraftKings
$49.00 /

+1.45 (+3.05%)

01/07/21 Piper Sandler
Penn National price target raised to $100 from $84 at Piper Sandler
01/06/21 Morgan Stanley
New York sports betting comments hint at higher tax rate, says Morgan Stanley
01/06/21 Oppenheimer
'A live NY' enables DraftKings to execute national ad strategy, says Oppenheimer
12/18/20 BofA
DraftKings price target raised to $60 from $55 at BofA
GTH Genetron
$15.66 /

+2.01 (+14.73%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
DNMR Danimer Scientific
$24.85 /

+2.2 (+9.71%)

01/06/21 Jefferies
Danimer Scientific initiated with a Buy at Jefferies
IMRA Imara
$14.69 /

-9.05 (-38.12%)

01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
NEO NeoGenomics
$51.35 /

-3.47 (-6.33%)

12/11/20 BTIG
NeoGenomics initiated with a Buy at BTIG
11/20/20 SVB Leerink
NeoGenomics price target raised to $50 from $47 at SVB Leerink
10/28/20 Needham
NeoGenomics price target raised to $46 from $39 at Needham
10/28/20 Craig-Hallum
NeoGenomics price target raised to $50 from $42 at Craig-Hallum
WBA Walgreens Boots Alliance
$43.05 /

+1.89 (+4.59%)

UNH UnitedHealth
$359.37 /

+14.85 (+4.31%)

TSLA Tesla
$756.20 /

+20.72 (+2.82%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

NEO NeoGenomics
$51.35 /

-3.47 (-6.33%)

MRNA Moderna
$116.27 /

+7.25 (+6.65%)

IMRA Imara
$14.69 /

-9.05 (-38.12%)

GTH Genetron
$15.66 /

+2.01 (+14.73%)

DKNG DraftKings
$49.00 /

+1.45 (+3.05%)

CHNG Change Healthcare
$23.72 /

+5.475 (+30.01%)

BABA Alibaba
$227.58 /

-12.84 (-5.34%)

ABC AmerisourceBergen
$106.15 /

+8.43 (+8.63%)

  • 07
    Jan
  • 07
    Oct
  • 07
    Aug
  • 19
    Jun
  • 19
    Jun
  • 19
    May
  • 30
    Apr
  • 12
    Mar
  • 14
    Feb
  • 12
    Feb
WBA Walgreens Boots Alliance
$43.05 /

+1.89 (+4.59%)

UNH UnitedHealth
$359.37 /

+14.85 (+4.31%)

TSLA Tesla
$756.20 /

+20.72 (+2.82%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

MRNA Moderna
$116.27 /

+7.25 (+6.65%)

DKNG DraftKings
$49.00 /

+1.45 (+3.05%)

CHL China Mobile
$27.70 /

-1.65 (-5.62%)

CHA China Telecom
$28.85 /

+0.33 (+1.16%)

BABA Alibaba
$227.58 /

-12.84 (-5.34%)

ABC AmerisourceBergen
$106.15 /

+8.43 (+8.63%)

WBA Walgreens Boots Alliance
$43.05 /

+1.89 (+4.59%)

UNH UnitedHealth
$359.37 /

+14.85 (+4.31%)

TSLA Tesla
$756.20 /

+20.72 (+2.82%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

NEO NeoGenomics
$51.35 /

-3.47 (-6.33%)

MRNA Moderna
$116.27 /

+7.25 (+6.65%)

GTH Genetron
$15.66 /

+2.01 (+14.73%)

DKNG DraftKings
$49.00 /

+1.45 (+3.05%)

CHNG Change Healthcare
$23.72 /

+5.475 (+30.01%)

BABA Alibaba
$227.58 /

-12.84 (-5.34%)

ABC AmerisourceBergen
$106.15 /

+8.43 (+8.63%)

WBA Walgreens Boots Alliance
$43.05 /

+1.89 (+4.59%)

UNH UnitedHealth
$359.37 /

+14.85 (+4.31%)

TSLA Tesla
$756.20 /

+20.72 (+2.82%)

MRNA Moderna
$116.27 /

+7.25 (+6.65%)

DKNG DraftKings
$49.00 /

+1.45 (+3.05%)

CHNG Change Healthcare
$23.72 /

+5.475 (+30.01%)

CHL China Mobile
$27.70 /

-1.65 (-5.62%)

BABA Alibaba
$227.58 /

-12.84 (-5.34%)

ABC AmerisourceBergen
$106.15 /

+8.43 (+8.63%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:38
01/06/21
01/06
12:38
01/06/21
12:38
MRNA

Moderna

$114.39 /

+5.37 (+4.93%)

, CHA

China Telecom

$26.91 /

-1.61 (-5.65%)

, CHL

China Mobile

$27.70 /

-1.65 (-5.62%)

, CHU

China Unicom

$6.10 /

-0.05 (-0.81%)

, ABC

AmerisourceBergen

$105.02 /

+7.3 (+7.47%)

, WBA

Walgreens Boots Alliance

$42.92 /

+1.76 (+4.28%)

, UNH

UnitedHealth

$347.00 /

+2.48 (+0.72%)

, CHNG

Change Healthcare

$23.86 /

+5.61 (+30.75%)

, TSLA

Tesla

$773.11 /

+37.63 (+5.12%)

, GTH

Genetron

$16.14 /

+2.49 (+18.24%)

, DNMR

Danimer Scientific

$26.28 /

+3.63 (+16.03%)

, IMRA

Imara

$15.30 /

-8.44 (-35.55%)

, NEO

NeoGenomics

$49.40 /

-5.42 (-9.89%)

Stock futures were mostly…

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$42.92 /

+1.76 (+4.28%)

UNH UnitedHealth
$347.00 /

+2.48 (+0.72%)

TSLA Tesla
$773.11 /

+37.63 (+5.12%)

NEO NeoGenomics
$49.40 /

-5.42 (-9.89%)

MRNA Moderna
$114.39 /

+5.37 (+4.93%)

IMRA Imara
$15.30 /

-8.44 (-35.55%)

GTH Genetron
$16.14 /

+2.49 (+18.24%)

DNMR Danimer Scientific
$26.28 /

+3.63 (+16.03%)

CHU China Unicom
$6.10 /

-0.05 (-0.81%)

CHNG Change Healthcare
$23.86 /

+5.61 (+30.75%)

CHL China Mobile
$27.70 /

-1.65 (-5.62%)

CHA China Telecom
$26.91 /

-1.61 (-5.65%)

ABC AmerisourceBergen
$105.02 /

+7.3 (+7.47%)

MRNA Moderna
$114.39 /

+5.37 (+4.93%)

01/04/21 Piper Sandler
Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/24/20 Piper Sandler
Piper calls Inovio's COVID vaccine candidate 'an also-ran' after data published
CHA China Telecom
$26.91 /

-1.61 (-5.65%)

03/24/20 CLSA
China Telecom upgraded to Outperform from Underperform at CLSA
03/24/20 Macquarie
China Telecom upgraded to Outperform from Neutral earlier at Macquarie
CHL China Mobile
$27.70 /

-1.65 (-5.62%)

07/13/20 New Street
China Mobile downgraded to Reduce from Neutral at New Street
03/19/20 New Street
China Mobile upgraded to Buy from Reduce at New Street
CHU China Unicom
$6.10 /

-0.05 (-0.81%)

09/30/20 Nomura
China Unicom upgraded to Buy from Neutral at Nomura
03/23/20 Macquarie
China Unicom upgraded to Outperform from Neutral at Macquarie
03/23/20 Credit Suisse
China Unicom upgraded to Outperform from Neutral at Credit Suisse
03/23/20 Credit Suisse
China Unicom upgraded to Outperform from Neutral at Credit Suisse
ABC AmerisourceBergen
$105.02 /

+7.3 (+7.47%)

01/06/21 BofA
AmerisourceBergen upgraded to Neutral from Underperform at BofA
11/18/20 Jefferies
Drug distributors' pullback on Amazon news an overreaction, says Jefferies
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
11/13/20 Mizuho
AmerisourceBergen price target raised to $104 from $100 at Mizuho
WBA Walgreens Boots Alliance
$42.92 /

+1.76 (+4.28%)

01/05/21 Truist
Walgreens Boots Alliance price target raised to $44 from $40 at Truist
12/04/20 Credit Suisse
Walgreens leverage buyout math 'could still work,' says Credit Suisse
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
UNH UnitedHealth
$347.00 /

+2.48 (+0.72%)

01/06/21 Raymond James
Change Healthcare downgraded to Market Perform from Strong Buy at Raymond James
01/06/21 Piper Sandler
Change Healthcare price target raised to $25.75 from $23 at Piper Sandler
01/06/21 William Blair
Change Healthcare downgraded to Market Perform from Outperform at William Blair
01/05/21 Truist
UnitedHealth price target raised to $420 from $400 at Truist
CHNG Change Healthcare
$23.86 /

+5.61 (+30.75%)

01/06/21 Baird
Change Healthcare downgraded to Neutral from Outperform at Baird
TSLA Tesla
$773.11 /

+37.63 (+5.12%)

01/06/21 Credit Suisse
Credit Suisse upgrades Li Auto to Outperform on sales momentum, autonomous plans
01/05/21 Morgan Stanley
Tesla price target raised to $810 from $540 at Morgan Stanley
01/05/21
Fly Intel: Top five analyst downgrades
01/05/21 Exane BNP Paribas
Exane downgrades Tesla to sell with $340 target on growing competition
GTH Genetron
$16.14 /

+2.49 (+18.24%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
DNMR Danimer Scientific
$26.28 /

+3.63 (+16.03%)

01/06/21 Jefferies
Danimer Scientific initiated with a Buy at Jefferies
IMRA Imara
$15.30 /

-8.44 (-35.55%)

01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
NEO NeoGenomics
$49.40 /

-5.42 (-9.89%)

12/11/20 BTIG
NeoGenomics initiated with a Buy at BTIG
11/20/20 SVB Leerink
NeoGenomics price target raised to $50 from $47 at SVB Leerink
10/28/20 Needham
NeoGenomics price target raised to $46 from $39 at Needham
10/28/20 Craig-Hallum
NeoGenomics price target raised to $50 from $42 at Craig-Hallum
WBA Walgreens Boots Alliance
$42.92 /

+1.76 (+4.28%)

UNH UnitedHealth
$347.00 /

+2.48 (+0.72%)

TSLA Tesla
$773.11 /

+37.63 (+5.12%)

NEO NeoGenomics
$49.40 /

-5.42 (-9.89%)

MRNA Moderna
$114.39 /

+5.37 (+4.93%)

IMRA Imara
$15.30 /

-8.44 (-35.55%)

GTH Genetron
$16.14 /

+2.49 (+18.24%)

CHNG Change Healthcare
$23.86 /

+5.61 (+30.75%)

ABC AmerisourceBergen
$105.02 /

+7.3 (+7.47%)

  • 07
    Jan
  • 07
    Aug
  • 19
    Jun
  • 19
    May
  • 30
    Apr
  • 12
    Mar
  • 14
    Feb
  • 12
    Feb
WBA Walgreens Boots Alliance
$42.92 /

+1.76 (+4.28%)

UNH UnitedHealth
$347.00 /

+2.48 (+0.72%)

TSLA Tesla
$773.11 /

+37.63 (+5.12%)

MRNA Moderna
$114.39 /

+5.37 (+4.93%)

CHL China Mobile
$27.70 /

-1.65 (-5.62%)

CHA China Telecom
$26.91 /

-1.61 (-5.65%)

ABC AmerisourceBergen
$105.02 /

+7.3 (+7.47%)

WBA Walgreens Boots Alliance
$42.92 /

+1.76 (+4.28%)

UNH UnitedHealth
$347.00 /

+2.48 (+0.72%)

TSLA Tesla
$773.11 /

+37.63 (+5.12%)

MRNA Moderna
$114.39 /

+5.37 (+4.93%)

GTH Genetron
$16.14 /

+2.49 (+18.24%)

CHNG Change Healthcare
$23.86 /

+5.61 (+30.75%)

CHA China Telecom
$26.91 /

-1.61 (-5.65%)

ABC AmerisourceBergen
$105.02 /

+7.3 (+7.47%)

WBA Walgreens Boots Alliance
$42.92 /

+1.76 (+4.28%)

UNH UnitedHealth
$347.00 /

+2.48 (+0.72%)

TSLA Tesla
$773.11 /

+37.63 (+5.12%)

MRNA Moderna
$114.39 /

+5.37 (+4.93%)

CHNG Change Healthcare
$23.86 /

+5.61 (+30.75%)

CHL China Mobile
$27.70 /

-1.65 (-5.62%)

ABC AmerisourceBergen
$105.02 /

+7.3 (+7.47%)

Hot Stocks
Genetron, CTTQ enter exclusive partnership agreement for HCCscreen » 05:08
01/06/21
01/06
05:08
01/06/21
05:08
GTH

Genetron

$13.65 /

-0.03 (-0.22%)

Genetron and Chia Tai…

Genetron and Chia Tai Tianqing Pharmaceutical, or CTTQ, a subsidiary of Sino Biopharmaceutical, announced an exclusive strategic partnership agreement for HCCscreen, Genetron Health's blood-based early screening test for hepatocellular carcinoma, or HCC, in China. This partnership targets the hospital market in China, with a focus on combatting liver disease, and marks Genetron Health's third commercialization initiative of HCCscreen in the country. Under the agreement, the companies will work together exclusively to co-market and co-promote HCCscreen in the hospital market, covering designated territories in China. The parties intend to target high-risk individuals for HCC, which include HBV-positive carriers, as well as other liver disease patients. Genetron will pay CTTQ a promotional fee based on a percentage of revenues generated from the collaboration. Contingent on certain sales and other requirements, the exclusivity period is expected to last three years. As a result of the agreement, Genetron expects HCCscreen revenues to further accelerate in China.

ShowHide Related Items >><<
GTH Genetron
$13.65 /

-0.03 (-0.22%)

GTH Genetron
$13.65 /

-0.03 (-0.22%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$13.65 /

-0.03 (-0.22%)

  • 19
    Jun
GTH Genetron
$13.65 /

-0.03 (-0.22%)

Over a quarter ago
Hot Stocks
Genetron says HCCscreen selected by NCC, Wuxi for public health initiative » 08:04
11/27/20
11/27
08:04
11/27/20
08:04
GTH

Genetron

$13.30 /

+0.81 (+6.49%)

Genetron Holdings…

Genetron Holdings provided an update for HCCscreen, its blood-based early screening test for hepatocellular carcinoma in China. Led by the Wuxi municipal government and administered by the National Cancer Center in China, the "Liver Cancer Early Screening Comprehensive Prevention and Control Project" is a public health initiative. The goal of the Project is to increase the awareness of liver cancer early screening, and to become a pilot city model in China. For the Project, Wuxi has selected HCCscreen for local residents who are high-risk individuals for HCC, and is committed to administering 150,000 tests over a period of three years. Wuxi had entered into a small-scale collaboration agreement with Genetron Health in 2019, and the Project represents an expanded collaboration between the parties. Wuxi is a city in the southern part of Jiangsu Province in eastern China with a population of over six million people, and has emerged as a biopharma innovation hub in recent years. Separately, Genetron Health has formed a new operating center through a joint venture agreement with Wuxi, in which the parties will closely collaborate on advancing the liver cancer early screening market in China, through the adoption of HCCscreen. Under this joint venture agreement, both parties will contribute capital, and Genetron Health will own 90% of the joint venture. In addition to the commitment of using HCCscreen for its residents, Wuxi will also provide Genetron Health with other supportive measures including rental, R&D subsidies and tax benefits.

ShowHide Related Items >><<
GTH Genetron
$13.30 /

+0.81 (+6.49%)

GTH Genetron
$13.30 /

+0.81 (+6.49%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$13.30 /

+0.81 (+6.49%)

  • 19
    Jun
GTH Genetron
$13.30 /

+0.81 (+6.49%)

Conference/Events
Canaccord to hold a virtual forum » 08:24
11/19/20
11/19
08:24
11/19/20
08:24
AFIB

Acutus Medical

$24.91 /

-0.56 (-2.20%)

, APYX

Apyx Medical

$7.02 /

+0.04 (+0.57%)

, ATRC

AtriCure

$40.81 /

+0.46 (+1.14%)

, AWH

Aspira Women's Health

$4.66 /

+0.025 (+0.54%)

, AXGN

AxoGen

$15.16 /

-0.05 (-0.33%)

, CSTL

Castle Biosciences

$46.27 /

-2.05 (-4.24%)

, GNMK

GenMark

$13.97 /

+0.31 (+2.27%)

, GTH

Genetron

$11.35 /

-0.29 (-2.49%)

, INMD

InMode

$42.75 /

+0.16 (+0.38%)

, KIDS

OrthoPediatrics

$44.84 /

-1.55 (-3.34%)

, LMAT

LeMaitre

$38.21 /

-0.485 (-1.25%)

, LUNG

Pulmonx

$46.50 /

-0.07 (-0.15%)

, NARI

Inari Medical

$65.75 /

-2.08 (-3.07%)

, PEN

Penumbra

$258.60 /

-1.595 (-0.61%)

, PODD

Insulet

$259.27 /

-0.18 (-0.07%)

, RCEL

Avita Medical

$22.80 /

+0.09 (+0.40%)

, SIEN

Sientra

$4.83 /

+ (+0.00%)

, SPNE

SeaSpine

$14.01 /

-0.05 (-0.36%)

, TCMD

Tactile Systems

$43.95 /

+1 (+2.33%)

, TMDX

TransMedics

$14.17 /

-0.33 (-2.28%)

, XENT

Intersect ENT

$18.15 /

-0.46 (-2.47%)

, XGN

Exagen

$15.03 /

-0.11 (-0.73%)

2020 Medical Technologies…

2020 Medical Technologies & Diagnostics Virtual Forum will be held on November 19.

ShowHide Related Items >><<
XGN Exagen
$15.03 /

-0.11 (-0.73%)

XENT Intersect ENT
$18.15 /

-0.46 (-2.47%)

TMDX TransMedics
$14.17 /

-0.33 (-2.28%)

TCMD Tactile Systems
$43.95 /

+1 (+2.33%)

SPNE SeaSpine
$14.01 /

-0.05 (-0.36%)

SIEN Sientra
$4.83 /

+ (+0.00%)

RCEL Avita Medical
$22.80 /

+0.09 (+0.40%)

PODD Insulet
$259.27 /

-0.18 (-0.07%)

PEN Penumbra
$258.60 /

-1.595 (-0.61%)

NARI Inari Medical
$65.75 /

-2.08 (-3.07%)

LMAT LeMaitre
$38.21 /

-0.485 (-1.25%)

KIDS OrthoPediatrics
$44.84 /

-1.55 (-3.34%)

INMD InMode
$42.75 /

+0.16 (+0.38%)

GTH Genetron
$11.35 /

-0.29 (-2.49%)

GNMK GenMark
$13.97 /

+0.31 (+2.27%)

CSTL Castle Biosciences
$46.27 /

-2.05 (-4.24%)

AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

AWH Aspira Women's Health
$4.66 /

+0.025 (+0.54%)

ATRC AtriCure
$40.81 /

+0.46 (+1.14%)

APYX Apyx Medical
$7.02 /

+0.04 (+0.57%)

AFIB Acutus Medical
$24.91 /

-0.56 (-2.20%)

AFIB Acutus Medical
$24.91 /

-0.56 (-2.20%)

08/31/20
Fly Intel: Top five analyst initiations
08/31/20 JPMorgan
Acutus Medical initiated with an Overweight at JPMorgan
08/31/20 William Blair
Acutus Medical initiated with an Outperform at William Blair
08/31/20 BTIG
Acutus Medical initiated with a Buy at BTIG
APYX Apyx Medical
$7.02 /

+0.04 (+0.57%)

06/22/20 Piper Sandler
Apyx Medical's expanded international sale 'important', says Piper Sandler
03/17/20 Piper Sandler
Apyx Medical price target lowered to $7 from $10 at Piper Sandler
01/13/20 JMP Securities
Apyx Medical shares likely to continue to appreciate, says JMP Securities
ATRC AtriCure
$40.81 /

+0.46 (+1.14%)

11/12/20 JPMorgan
JPMorgan a buyer of AtriCure ahead of 'major catalyst'
09/30/20 Piper Sandler
Piper Sandler 'highly' recommends five names in Medical Technology
07/29/20 SVB Leerink
AtriCure price target raised to $60 from $55 at SVB Leerink
07/29/20 Piper Sandler
AtriCure price target raised to $50 from $47 at Piper Sandler
AWH Aspira Women's Health
$4.66 /

+0.025 (+0.54%)

10/29/20 William Blair
Aspira Women's Health initiated with an Outperform at William Blair
AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

10/22/20 Guggenheim
AxoGen initiated with a Buy at Guggenheim
06/16/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
AxoGen assumed with an Overweight at Cantor Fitzgerald
05/07/20 Canaccord
AxoGen downgraded to Hold at Canaccord
CSTL Castle Biosciences
$46.27 /

-2.05 (-4.24%)

11/09/20 KeyBanc
Castle Biosciences initiated with an Overweight at KeyBanc
10/13/20 Canaccord
Castle Biosciences price target raised to $61 from $52 at Canaccord
09/25/20 SVB Leerink
Castle Biosciences price target raised to $57 from $50 at SVB Leerink
09/03/20 Canaccord
Castle Biosciences price target raised to $52 from $47 at Canaccord
GNMK GenMark
$13.97 /

+0.31 (+2.27%)

10/09/20 Canaccord
Execution positions GenMark for long-term success, says Canaccord
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/05/20 Canaccord
GenMark price target raised to $22 from $20 at Canaccord
07/08/20 BTIG
GenMark price target raised to $18 from $14 at BTIG
GTH Genetron
$11.35 /

-0.29 (-2.49%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
INMD InMode
$42.75 /

+0.16 (+0.38%)

10/21/20 Canaccord
InMode price target raised to $51 from $42 at Canaccord
10/13/20 Baird
InMode price target raised to $55 from $43 at Baird
02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
KIDS OrthoPediatrics
$44.84 /

-1.55 (-3.34%)

10/07/20 BTIG
OrthoPediatrics price target raised to $57 from $54 at BTIG
08/06/20 Piper Sandler
Piper says OrthoPediatrics can win in 'more muted competitive environment'
08/06/20 Needham
OrthoPediatrics price target raised to $57 from $49 at Needham
06/23/20 Piper Sandler
OrthoPediatrics recovery better than expected, says Piper Sandler
LMAT LeMaitre
$38.21 /

-0.485 (-1.25%)

10/30/20 Barrington
LeMaitre price target raised to $46 from $36 at Barrington
10/28/20 Barrington
Varian Medical downgraded to Underperform from Outperform at Barrington
07/24/20 Lake Street
LeMaitre price target raised to $38 from $33 at Lake Street
05/04/20 Roth Capital
LeMaitre price target lowered to $28 from $32.50 at Roth Capital
LUNG Pulmonx
$46.50 /

-0.07 (-0.15%)

10/26/20 BofA
Pulmonx initiated with a Buy at BofA
10/26/20 Canaccord
Pulmonx initiated with a Buy at Canaccord
10/26/20 Morgan Stanley
Pulmonx initiated with an Equal Weight at Morgan Stanley
10/26/20 Stifel
Pulmonx initiated with a Buy at Stifel
NARI Inari Medical
$65.75 /

-2.08 (-3.07%)

11/18/20
Fly Intel: Top five analyst initiations
11/18/20 BTIG
Inari Medical initiated with a Buy at BTIG
11/13/20 SVB Leerink
Inari Medical price target raised to $90 from $80 at SVB Leerink
10/29/20 Morgan Stanley
Morgan Stanley upgrades Inari Medical on 'clear signs' of VTE inflection
PEN Penumbra
$258.60 /

-1.595 (-0.61%)

10/29/20 Canaccord
Penumbra price target raised to $292 from $253 at Canaccord
10/29/20 Wells Fargo
Penumbra price target raised to $265 from $255 at Wells Fargo
10/29/20 JPMorgan
JPMorgan ups Penumbra target, reiterates as top pick into 2021
PODD Insulet
$259.27 /

-0.18 (-0.07%)

11/05/20 Wells Fargo
Insulet price target raised to $266 from $250 at Wells Fargo
11/03/20 Piper Sandler
Clinical Trials update positive for Insulet, says Piper Sandler
10/16/20 Citi
Citi opens 'positive catalyst watch' on DexCom
08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
RCEL Avita Medical
$22.80 /

+0.09 (+0.40%)

08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
SIEN Sientra
$4.83 /

+ (+0.00%)

10/08/20 Stifel
Stifel sees upside potential for Sientra after survey of aesthetics doctors
06/11/20 Maxim
Sientra price target raised to $8 from $5 at Maxim
03/12/20 Craig-Hallum
Sientra price target lowered to $9 from $14 at Craig-Hallum
03/12/20 SVB Leerink
Sientra price target lowered to $6.50 from $13 at SVB Leerink
SPNE SeaSpine
$14.01 /

-0.05 (-0.36%)

10/19/20 Stifel
SeaSpine initiated with a Buy at Stifel
10/06/20 Piper Sandler
SeaSpine remains 'must-own SMID-cap name,' says Piper Sandler
08/05/20 Piper Sandler
SeaSpine remains 'must own SMID name' at Piper Sandler
06/16/20 Cantor Fitzgerald
SeaSpine assumed with an Overweight at Cantor Fitzgerald
TCMD Tactile Systems
$43.95 /

+1 (+2.33%)

11/13/20 Oppenheimer
Tactile Systems upgraded to Outperform from Perform at Oppenheimer
11/13/20 Oppenheimer
Tactile Systems upgraded to Outperform from Perform at Oppenheimer
11/03/20 Piper Sandler
Tactile Systems shares still recommended after results at Piper Sandler
TMDX TransMedics
$14.17 /

-0.33 (-2.28%)

10/08/20
Fly Intel: Top five analyst downgrades
10/08/20 JPMorgan
TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
10/08/20 JPMorgan
TransMedics downgraded to Neutral from Overweight at JPMorgan
09/29/20 Canaccord
TransMedics story intact despite OCS Heart delay, says Canaccord
XENT Intersect ENT
$18.15 /

-0.46 (-2.47%)

11/19/20 BTIG
Intersect ENT upgraded to Buy from Neutral at BTIG
11/02/20 Piper Sandler
Intersect ENT price target raised to $17 from $16 at Piper Sandler
10/22/20 Piper Sandler
Intersect ENT price target lowered to $16 from $17 at Piper Sandler
10/15/20 Piper Sandler
Intersect ENT shares may be pressured by below-consensus Q4, says Piper Sandler
XGN Exagen
$15.03 /

-0.11 (-0.73%)

11/09/20 KeyBanc
Exagen initiated with an Overweight at KeyBanc
10/07/20 BTIG
Exagen assumed with a Buy at BTIG
06/02/20 Cantor Fitzgerald
Exagen assumed with an Overweight at Cantor Fitzgerald
06/01/20 Cantor Fitzgerald
Exagen assumed with an Overweight at Cantor Fitzgerald
XGN Exagen
$15.03 /

-0.11 (-0.73%)

XENT Intersect ENT
$18.15 /

-0.46 (-2.47%)

TMDX TransMedics
$14.17 /

-0.33 (-2.28%)

TCMD Tactile Systems
$43.95 /

+1 (+2.33%)

SPNE SeaSpine
$14.01 /

-0.05 (-0.36%)

SIEN Sientra
$4.83 /

+ (+0.00%)

PODD Insulet
$259.27 /

-0.18 (-0.07%)

PEN Penumbra
$258.60 /

-1.595 (-0.61%)

NARI Inari Medical
$65.75 /

-2.08 (-3.07%)

LMAT LeMaitre
$38.21 /

-0.485 (-1.25%)

KIDS OrthoPediatrics
$44.84 /

-1.55 (-3.34%)

INMD InMode
$42.75 /

+0.16 (+0.38%)

GTH Genetron
$11.35 /

-0.29 (-2.49%)

GNMK GenMark
$13.97 /

+0.31 (+2.27%)

CSTL Castle Biosciences
$46.27 /

-2.05 (-4.24%)

AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

ATRC AtriCure
$40.81 /

+0.46 (+1.14%)

APYX Apyx Medical
$7.02 /

+0.04 (+0.57%)

AFIB Acutus Medical
$24.91 /

-0.56 (-2.20%)

  • 01
    Oct
  • 06
    Aug
  • 25
    Jun
  • 18
    Jun
  • 19
    Jun
  • 28
    May
  • 27
    May
  • 22
    May
  • 13
    May
  • 12
    May
  • 07
    May
  • 08
    Jan
  • 11
    Dec
XENT Intersect ENT
$18.15 /

-0.46 (-2.47%)

PEN Penumbra
$258.60 /

-1.595 (-0.61%)

ATRC AtriCure
$40.81 /

+0.46 (+1.14%)

XENT Intersect ENT
$18.15 /

-0.46 (-2.47%)

TMDX TransMedics
$14.17 /

-0.33 (-2.28%)

SPNE SeaSpine
$14.01 /

-0.05 (-0.36%)

PODD Insulet
$259.27 /

-0.18 (-0.07%)

PEN Penumbra
$258.60 /

-1.595 (-0.61%)

NARI Inari Medical
$65.75 /

-2.08 (-3.07%)

LUNG Pulmonx
$46.50 /

-0.07 (-0.15%)

LMAT LeMaitre
$38.21 /

-0.485 (-1.25%)

KIDS OrthoPediatrics
$44.84 /

-1.55 (-3.34%)

GTH Genetron
$11.35 /

-0.29 (-2.49%)

GNMK GenMark
$13.97 /

+0.31 (+2.27%)

CSTL Castle Biosciences
$46.27 /

-2.05 (-4.24%)

AXGN AxoGen
$15.16 /

-0.05 (-0.33%)

APYX Apyx Medical
$7.02 /

+0.04 (+0.57%)

AFIB Acutus Medical
$24.91 /

-0.56 (-2.20%)

TMDX TransMedics
$14.17 /

-0.33 (-2.28%)

NARI Inari Medical
$65.75 /

-2.08 (-3.07%)

CSTL Castle Biosciences
$46.27 /

-2.05 (-4.24%)

AWH Aspira Women's Health
$4.66 /

+0.025 (+0.54%)

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
11/18/20
11/18
04:55
11/18/20
04:55
GTH

Genetron

$11.64 /

-0.48 (-3.96%)

, HCM

Hutchison China MediTech

$31.21 /

+0.86 (+2.83%)

, IMAB

I-MAB

$37.89 /

+0.76 (+2.05%)

Asia Pacific Healthcare…

Asia Pacific Healthcare Virtual Forum 2020 will be held on November 16-18.

ShowHide Related Items >><<
IMAB I-MAB
$37.89 /

+0.76 (+2.05%)

HCM Hutchison China MediTech
$31.21 /

+0.86 (+2.83%)

GTH Genetron
$11.64 /

-0.48 (-3.96%)

GTH Genetron
$11.64 /

-0.48 (-3.96%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
HCM Hutchison China MediTech
$31.21 /

+0.86 (+2.83%)

10/02/20 Deutsche Bank
Hutchison China MediTech initiated with a Buy at Deutsche Bank
03/13/20
Fly Intel: Top analyst initiations
03/12/20 Cantor Fitzgerald
Hutchison China MediTech initiated with an Overweight at Cantor Fitzgerald
02/20/20
Fly Intel: Top five analyst initiations
IMAB I-MAB
$37.89 /

+0.76 (+2.05%)

09/08/20 Cantor Fitzgerald
I-MAB price target raised to $55 from $50 at Cantor Fitzgerald
07/27/20 Cantor Fitzgerald
I-MAB initiated with an Overweight at Cantor Fitzgerald
02/14/20
Fly Intel: Top five analyst initiations
02/13/20 CICC
I-MAB initiated with an Outperform at CICC
HCM Hutchison China MediTech
$31.21 /

+0.86 (+2.83%)

GTH Genetron
$11.64 /

-0.48 (-3.96%)

  • 19
    Jun
  • 23
    Jan
  • 17
    Jan
IMAB I-MAB
$37.89 /

+0.76 (+2.05%)

GTH Genetron
$11.64 /

-0.48 (-3.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.